Phase
Condition
Arrhythmia
Dysrhythmia
Chest Pain
Treatment
Noninvasive mapping (Cardioinsight® system)
long-term cardiac monitoring (LINQ system)
Atrial Fibrillation ablation procedure
Clinical Study ID
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients with documented persistent Atrial Fibrillation lasting longer than 6 monthsdocumented by 24h holter monitoring
Age between 18 and 75 years
Efficient oral anticoagulation during at least 1 month before the procedure
Social security affiliation
Feasible patient follow-up
Patient willing to comply with study requirements and give informed consent toparticipate in this clinical study
Indication for Pulmonary Vein isolation
Exclusion
Exclusion Criteria:
Previous atrial fibrillation ablation
Previous left atrial ablation or surgery
Atrial fibrillation without spontaneous RR interval > 1000ms and with LVEF < 35% (measured by TTE)
Presence of a mechanical mitral valve
Current intracardiac thrombus
Any condition contraindicating chronic anticoagulation
Uncontrolled hyperthyroidism
Anteroposterior LA diameter > 55 mm measured by TTE
Body mass index ≥ 40 kg/m2
Study Design
Connect with a study center
Caen University Hospital
Caen,
FranceSite Not Available
Caen University Hospital
Caen 3029241,
FranceSite Not Available
Dieppe Hospital
Dieppe,
FranceSite Not Available
Dieppe Hospital
Dieppe 3021411,
FranceSite Not Available
Groupe Hospitalier du Havre
Le Havre,
FranceSite Not Available
Groupe Hospitalier du Havre
Le Havre 3003796,
FranceSite Not Available
Rouen University Hospital
Rouen,
FranceSite Not Available
Rouen University Hospital
Rouen 2982652,
FranceSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.